Post-radiosynovectomy imaging utilizing Erbium-169 citrate
Applied Radiation and Isotopes, 2019Currently, there is no imaging procedure for radionuclide therapy utilizing Erbium-169 (Er-169). We have recently published the first post-radiosynovectomy imaging of Er-169 citrate in a case report (Farahati et al., 2017). In this study, we performed in-vitro and in-vivo studies to evaluate the feasibility to assess the distribution of Er-169 citrate ...
Jamshid Farahati +2 more
exaly +4 more sources
Radiosynovectomy: Science and Practice [PDF]
, 2012 While for the majority of the patients, rheumatoid and other arthritis can be controlled satisfactorily, long-term systemic therapy fails in some cases and not only its side effects accumulate to a serious level. Radiosynovectomy should be used timely after long-term systemic pharmacotherapy or intra-articular steroid injections have failed. The method
Peter Schneider
openaire +2 more sources
Preparation of 188Re-labeled hydroxyapatite for radiosynovectomy [PDF]
Journal of Radioanalytical and Nuclear Chemistry, 2002 Hydroxyapatite (HA), a natural constituent of bone, was synthesized. HA particles were radiolabeled with 188Re. Radiolabeling efficiency was 95%. In vitro studies showed 5% loss of activity from particles in normal saline over a period of 2 days, whereas a dissociation rate of 9% was observed in human serum albumin.
S. Pervez, A. Mushtaq, M. Arif
openaire +2 more sources
Post-radiosynovectomy 90Y-PET imaging [PDF]
Nuklearmedizin, 2011 Prechtel, H.W. +5 more
core +5 more sources
Long‐term outcomes in haemophilic synovitis after radiosynovectomy using rhenium‐186: a single‐centre experience [PDF]
Haemophilia, 2013 Radiosynovectomy has been performed successfully for more than 10years in our hospital. This study investigated the long-term outcome in the context of time to progression (TTP) analysis and the factors influencing TTP following radiosynovectomy with Re ...
Bulent Zulfikar
exaly +2 more sources
EANM Procedure Guidelines for Radiosynovectomy [PDF]
European Journal of Nuclear Medicine and Molecular Imaging, 2003 G, Clunie, M, Fischer
openaire +3 more sources
Radiosynovectomy in Hemophilic Synovitis: Correlation of Therapeutic Response and Blood-Pool Changes [PDF]
Cancer Biotherapy and Radiopharmaceuticals, 2005 Aim: The aim of this study was to evaluate the efficacy of Y-90 and Re-186 radiosynovectomy in patients with hemophilic synovitis. Methods: Radiosynovectomy was performed in 32 joints of 20 patients with hemophilic synovitis by using Y-90 citrate colloid
Cuneyt Turkmen +2 more
exaly +2 more sources
Prognostic factors of radiosynovectomy in haemophilia patients with inhibitors: Survival analysis in a 19‐year period [PDF]
Haemophilia, 2020 Introduction People with haemophilia (PwH) with inhibitors have an increased risk of bleeding and early development of progressive arthropathy. Radiosynovectomy (RS) has been effective in dramatically reducing the frequency of haemarthroses.
Cuneyt Turkmen +2 more
exaly +2 more sources
Survival analysis of Y‐90 radiosynovectomy in the treatment of haemophilic synovitis of the knee: a 10‐year retrospective review [PDF]
Haemophilia, 2014 Despite recent advances including new therapeutic options and availability of primary prophylaxis in haemophiliacs, haemophilic synovitis is still the major clinical problem in significant patient population worldwide.
Serkan Kuyumcu, Bulent Zulfikar
exaly +2 more sources
RADIATION PROTECTION IN RADIOSYNOVECTOMY OF THE KNEE
Health Physics, 2005Radiosynovectomy is a widely available therapeutic option that involves radiopharmaceutical injections into joints to treat rheumatoid arthritis. However, data on the beta-radiation dose equivalents for the staff performing such treatments are limited.
Knut, Liepe +3 more
openaire +2 more sources